Raghavendra Vasudeva
Overview
Explore the profile of Raghavendra Vasudeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lipton R, Baygani S, Tepper S, Krege J, Vasudeva R, Pearlman E, et al.
J Headache Pain
. 2021 Aug;
22(1):101.
PMID: 34454420
Background: While pain freedom at 2 h is a key primary outcome for current trials for acute treatment of migraine, the relationship between the degree of head pain and other...
2.
Peres M, Vasudeva R, Baygani S, Dennehy E, Vincent M, Friedman D
Curr Med Res Opin
. 2021 Mar;
37(6):1031-1038.
PMID: 33784930
Objective: To evaluate the efficacy of lasmiditan (LTN) in treating migraine attacks of mild vs. moderate or severe pain intensity. Methods: Pooled data from two single-attack, placebo-controlled studies (SAMURAI [NCT02439320]...
3.
Tepper S, Vasudeva R, Krege J, Rathmann S, Doty E, Vargas B, et al.
Headache
. 2020 Jul;
60(8):1601-1615.
PMID: 32634275
Objective: To identify factors predicting response (2-hour headache pain freedom or most bothersome symptom freedom) to lasmiditan based on individual patient characteristics, migraine disease characteristics, and migraine attack characteristics. Further,...
4.
Ashina M, Vasudeva R, Jin L, Lombard L, Gray E, Doty E, et al.
Headache
. 2019 Sep;
59(10):1788-1801.
PMID: 31529622
Objective: To expand on available information on the efficacy of oral lasmiditan for the acute treatment of migraine with particular focus on the timing of the effect and on its...
5.
Brandes J, Klise S, Krege J, Case M, Khanna R, Vasudeva R, et al.
Cephalalgia
. 2019 Aug;
39(11):1343-1357.
PMID: 31433669
Objectives: To address the need for long-term lasmiditan data, the GLADIATOR study evaluated the safety (primary) and efficacy (secondary) of lasmiditan for the intermittent, acute treatment of migraine attacks for...